Concern points and considerations for pharmacodynamic study design of new traditional Chinese medicines.
- Author:
Fang-Hua HUANG
- Publication Type:Journal Article
- MeSH:
Humans;
Medicine, Chinese Traditional;
methods;
Pharmacokinetics
- From:
China Journal of Chinese Materia Medica
2014;39(6):1136-1139
- CountryChina
- Language:Chinese
-
Abstract:
Pharmacodynamic (PD) studies play an important role in research and development of new traditonal Chinese medicines (TCMs). Phamacologic and toxicologic studies that aim to research drug ability can provide supporting data for the clinical trials and reduce the risk of clinical trials. In recent years, PD studies in TCMs are developing and progressing, but there are still some problems affecting the value of PD studies in the development of new TCMs. The value of PD studies depends on scientific and rational study design. This article summaries some defects in PD study design of new TCMs that are common in the application data, including defects in study type, testing targets, dosing, duration of administration, control group, testing time. This article also discusses some points of concern and specific requirements for PD study design of new TCMs.
